Summit Securities Group’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.84K Buy
23
+7
+44% +$1.5K ﹤0.01% 981
2026
Q1
$3.54K Sell
16
-129
-89% -$31.6K ﹤0.01% 862
2025
Q4
$36.8K Sell
145
-26
-15% -$6.53K ﹤0.01% 682
2025
Q3
$42.3K Buy
171
+105
+159% +$25.1K 0.01% 604
2025
Q2
$15.9K Buy
+66
New +$15.4K ﹤0.01% 787
2023
Q3
Sell
-129
Closed -$29K 988
2023
Q2
$29K Sell
129
-65
-34% -$13K ﹤0.01% 545
2023
Q1
$37K Sell
194
-1,535
-89% -$297K ﹤0.01% 487
2022
Q4
$319K Buy
1,729
+1,728
+172,800% +$304K 0.01% 347
2022
Q3
$0 Sell
1
-210
-100% -$42.7K ﹤0.01% 1155
2022
Q2
$43K Buy
211
+170
+415% +$38.3K 0.01% 592
2022
Q1
$10K Buy
+41
New +$9.5K ﹤0.01% 847

Other funds holding STE

Summit Securities Group's STE Position: Q2 2026 in Review

Summit Securities Group increased its Steris (STE) stake by 44% in Q2 2026, buying an estimated $1.5K and bringing the position to 23 shares worth $4.84K. The position accounts for ﹤0.01% of the portfolio, ranked #981.

Summit Securities Group first reported a position in STE in Q1 2022 and has held it in 11 quarters since. The position peaked at $319K in Q4 2022. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Summit Securities Group held 23 shares of Steris worth $4.84K as of Q2 2026.
  • Summit Securities Group bought 7 Steris shares in Q2 2026, an estimated $1.5K.
  • Steris made up ﹤0.01% of Summit Securities Group's portfolio in Q2 2026, its #981 holding.
  • Summit Securities Group first reported a position in Steris in Q1 2022 and has held it in 11 quarters since.
  • Summit Securities Group's Steris position peaked at $319K in Q4 2022.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.